|Applying Next-Generation Sequencing and Other Diagnostic Challenges in MDS |
Jay L. Patel, MD, and Eric Padron, MD
|Release Date: February 07, 2019|
Expiration Date: February 07, 2020
Oncology nurses face a number of challenges when treating patients with myelodysplastic syndromes. For one, it can be difficult to navigate between the emerging therapies and diagnostic guidelines. In this activity, Dr. Patel will address strategies for applying next-generation sequencing in the management of patients with MDS. Another challenge nurses face is the molecular basis of MDS and its requirements for diagnosis. Dr. Padron discusses which diagnostic criteria to utilize in your practice.Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Onconova Therapeutics Inc.
|Begin, Earn CreditView Only, No Credit|